Login

Jon Pilcher, CEO, Neuren Pharmaceuticals Ltd 00:00:00

Share On Facebook Share On Twitter

Neuren Pharmaceuticals hails FDA approval for trofinetide

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Erik Kinnman, CEO, NeuroVive Pharmaceutical
00:10:00
The Secrets to Raising Money|Ariel Sterman,Vice President,Bessemer Venture Partners
00:10:00
Pioneering prediction and prevention in dermatology|Pia Renaudin, CEO,SciBase Holdings
00:10:00
Emerging Managers & How to Evaluate Founder Passion|Richard Kerby,Co-Founder and General Partner,Equal Ventures
00:10:00
Artemis Resources' Strategic Ventures and Exploration Achievements in Western Australia: Highlights from the One-to-One Mining Investment Conference
00:10:00
PRIMARY FOCUS IS ON DISCOVERY POTENTIAL WITH MULTIPLE OPPORTUNITIES IN STABLE OPERATING JURISDICTIONS THAT INCLUDES OVER 240,000 Ha OF PROSPECTIVE GROUND IN SASKATCHEWAN|Warren Stanyer,CEO,ALX Resources Corp
00:00:00
Dr. Dawn Jaroszewski, Mayo Clinic
00:10:00
Dropbox CEO Drew Houston joins CNBC's "Closing Bell" for an exclusive interview after the company's strong earnings report.|Andrew W. Houston is an American Internet entrepreneur, and the co-founder and CEO of Dropbox
00:10:00
3R Petroleum: How do the company's processes work? | Matheus Dias de Siqueira, CEO, 3R Petroleum Oleo e Gas SARRRP3:SAO
00:10:00
Conversation on Development Finance and Africa's Role in Global Investments | Tellef Thorleifsson, CEO, Norfund.
00:10:00
Investor Perspectives: Insights from Marco on Mining Sector Trends
00:10:00
Kelly Partners: Transforming Accounting with a Modern Approach and Significant Growth Potential

© 2017 - Neuhu+